Publications

PloS one

A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

31-03-2016

BMJ open

Effectiveness of a multicentre nasopharyngeal carcinoma awareness programme in Indonesia.

01-03-2016

Breast cancer research : BCR

Genetic predisposition to ductal carcinoma in situ of the breast.

17-02-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

10-02-2016

BMC medical ethics

Exceptions to the rule of informed consent for research with an intervention.

06-02-2016

British journal of cancer

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.

02-02-2016

British journal of cancer

Gene-environment interaction and risk of breast cancer.

19-01-2016

Human genetics

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

01-01-2016

BMC cancer

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

16-12-2015

Oncotarget

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival.

10-11-2015

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

01-11-2015

Journal of the National Cancer Institute

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

01-11-2015

Nature genetics

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.

01-11-2015

Familial cancer

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.

01-09-2015

Pharmacoepidemiology and drug safety

Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.

01-09-2015

Breast cancer research : BCR

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.

05-08-2015

BMC medicine

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

02-07-2015

American journal of human genetics

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

02-07-2015

EBioMedicine

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.

01-07-2015

Human molecular genetics

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

15-05-2015

Journal of the National Cancer Institute

Prediction of breast cancer risk based on profiling with common genetic variants.

01-05-2015

European journal of human genetics : EJHG

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.

01-05-2015

Journal of the National Cancer Institute

Identification of novel genetic markers of breast cancer survival.

01-05-2015

Breast cancer research : BCR

Common germline polymorphisms associated with breast cancer-specific survival.

22-04-2015

Oncotarget

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.

10-04-2015

Nature genetics

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

01-04-2015

PloS one

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.

31-03-2015

Carcinogenesis

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

01-02-2015

American journal of human genetics

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

08-01-2015

Human molecular genetics

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

01-01-2015

The journal of pathology. Clinical research

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

01-01-2015

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

01-01-2015

Human molecular genetics

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

15-11-2014

Human molecular genetics

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

15-11-2014

PloS one

MicroRNA related polymorphisms and breast cancer risk.

13-11-2014

Nature

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.

02-10-2014

Nature communications

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

23-09-2014

Nature communications

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.

17-06-2014

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.

01-06-2014

Breast cancer research and treatment

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.

01-06-2014

Breast cancer research : BCR

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

26-05-2014

Nederlands tijdschrift voor geneeskunde

[Gene expression classifiers in the prognosis of breast cancer].

02-05-2014

PLoS genetics

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

01-04-2014

Cancer biology & therapy

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy.

01-04-2014

European journal of cancer (Oxford, England : 1990)

Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature.

01-04-2014

Breast cancer research and treatment

Long-term impact of the 70-gene signature on breast cancer outcome.

01-02-2014

Breast cancer research and treatment

Mammographic screening detects low-risk tumor biology breast cancers.

01-02-2014

Nederlands tijdschrift voor geneeskunde

[Biobanks and the return of results to donors].

30-01-2014

Nederlands tijdschrift voor geneeskunde

[Consent for the secondary use of human residual tissue: the patient is best served by an 'opting-out' procedure].

24-05-2012

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer.

01-01-2012

A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

Effectiveness of a multicentre nasopharyngeal carcinoma awareness programme in Indonesia.

Genetic predisposition to ductal carcinoma in situ of the breast.

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

Exceptions to the rule of informed consent for research with an intervention.

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.

Gene-environment interaction and risk of breast cancer.

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival.

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.

Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

Prediction of breast cancer risk based on profiling with common genetic variants.

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.

Identification of novel genetic markers of breast cancer survival.

Common germline polymorphisms associated with breast cancer-specific survival.

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

MicroRNA related polymorphisms and breast cancer risk.

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.

Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

[Gene expression classifiers in the prognosis of breast cancer].

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy.

Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature.

Long-term impact of the 70-gene signature on breast cancer outcome.

Mammographic screening detects low-risk tumor biology breast cancers.

[Biobanks and the return of results to donors].

[Consent for the secondary use of human residual tissue: the patient is best served by an 'opting-out' procedure].

Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer.

This site uses cookies